Antitumor efficacy of reticulol from Streptoverticillium against the lung metastasis model B16F10 melanoma: Lung metastasis inhibition by growth inhibition of melanoma

Chemotherapy

Volumn 49, Issue 3, 2003, Pages 146-153

  Lim, Dae Seog ^a   Kwak, Yi Sub ^b   Kim, Jeong Hwan ^a   Ko, Si Hwan ^c   Yoon, Won Ho ^d   Kim, Chang Han ^a  

^a Konkuk University   (South Korea)

^b Dong Eui University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Seoil University   (South Korea)

Author keywords

Antitumor activity; B16F10 melanoma; Lung tumor metastasis; Reticulol

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; GELATINASE A; GELATINASE B; PHOSPHODIESTERASE INHIBITOR; RETICULOL; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD FLOW; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG TUMOR; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOVERTICILLIUM; TUMOR CELL LINE; ZYMOGRAPHY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; COUMARINS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFUSIONS, PARENTERAL; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NECROSIS; NEOPLASMS, EXPERIMENTAL;

EID: 0038647340     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070621     Document Type: Article

References (27)

1. Lim D-S, Yoon S-K, Lee M-S, Yoon W-H, Kim C-H: Isolation and identification of Streptoverticillium sp. NA-4803 producing antifungal substance. Kor J Appl Microbiol Biotechnol 1996;24:664-670.
2. Mitscher LA, Andres WW, McCrae W: Reticulol, a new metabolic isocoumarin. Experientia 1964;20:258-259.
3. Furutani Y, Shimada M, Hamada M, Takeuchi T, Umezawa H: Reticulol, an inhibitor of cyclic adenosine 3′,5′-monophosphate phosphodiesterase. J Antibiot (Tokyo) 1975;28:558-560.
4. Eaton MAW, Hutchinson DW: Isocoumarins from Streptomyces mobaraensis. Tetrahedron Lett 1971;18:1337-1340.
5. Lin J, Yoshida S, Takahashi N: Metabolites produced by Streptomyces mobaraensis. Agric Biol Chem 1971;35:363-369.
6. Otcenasek M, Dvorak J: Griseofulvin-Sensitivitätstest in vitro als Hilfsmethode zur Unterscheidung von Trichophyton mentagrophytes und T. rubrum. Zentralbl Bakteriol Mikrobiol Hyg I Abt Orig 1971;217:96-103.
7. Shi Y, Parhar RS, Zou M, Al-Mohanna FA, Paterson MC: Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1. Cancer Gene Ther 2002; 9:126-132.
8. Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS, Lee DY: Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett 2001;172:83-91.
9. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-188.
10. Grossman D, Altieri DC: Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 2001;20:3-11.
11. Weinstat-Saslow D, Steeg PS: Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances. FASEB J 1994;8:401-407.
12. Togawa D, Koshino T, Saito T, Takagi T, Machida J: Highly activated matrix metalloproteinase-2 secreted from clones of metastatic lung nodules of nude mice injected with human fibrosarcoma HT1080. Cancer Lett 1999;146:25-33.
13. Brown LM, Welch DR, Rannels DE, Rannels SR: Partial pneumonectomy enhances melanoma metastasis to mouse lungs. Chest 2002;121:28S-29S.
14. Matsumoto Y, Ikemoto A, Tawara S: Antibacterial activity of cefixime against Salmonella typhiand applicability of Etest. J Infest Chemother 1999;5:176-179.
15. Kern DH, Bertelsen CA, Mann BD, Campbell MA, Morton DC, Cochran AJ: Clinical application of the clonogenic assay. Ann Clin Lab Sci 1983;13:10-15.
16. Sato T, Nagai K, Suzuki K, Morioka M, Saito T: A new isocoumarin antibiotic, Y-05460M-A. J Antibiot (Tokyo) 1992;45:1949-1952.
17. 13C NMR. Phytochemistry 1997;44:267-269.
18. Kumagai H, Amemiya M, Naganawa H, Sawa T, Ishizuka M, Takeuchi T: Biosynthesis of antitumor antibiotic, cytogenin. J Antibiot (Tokyo) 1994;47:440-446.
19. Kam CM, Fujikawa K, Powers JC: Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: New anticoagulants. Biochemistry 1988;27:2547-2557.
20. Stadler M, Anke H: Metabolites with nematicidal, and antimicrobial activities from the ascomycete Lachnum papyraceum (Karst.) Karst. 3. Production of novel isocoumarin derivatives, isolation, and biological activities. J Antibiot (Tokyo) 1995;48:261-266.
21. Yamamoto H, Irie A, Fukushima Y, Onishi T, Arita N, Hayakawa T, Sekiguchi K: Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin-α6 subunit expression. Int J Cancer 1996;65:519-524.
22. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
23. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer E, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988;263:6579-6587.
24. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D: Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 2001;20:8066-8074.
25. Grdina DJ, Kataoka Y, Murley JS, Hunter N, Weichselbaum RR, Milas L: Inhibition of spontaneous metastases formation by amifostine. Int J Cancer 2002;97:135-141.
26. Granada TC, Artis WM: Factors affecting griseofulvin susceptibility testing of Trichophyton rubrum in microcultures. J Clin Microbiol 1982;16:1043-1047.
27. Kobayashi H, Namikoshi M, Yoshimoto T, Yokochi T: A screening method for antimitotic and antifungal substances using conidia of Pyricularia oryzae, modification and application to tropical marine fungi. J Antibiot (Tokyo) 1996;49:873-879.